Who
James G. Coulter
Executive Chairman
Company insider
Files Form 4 as: Executive Chairman, Tpg; Other, CeriBell; Other, Odyssey Therapeutics; 10% owner, TPG Twin Brook Capital Income Fund; 10% owner, Sionna Therapeutics; Other, ServiceTitan; Director and 10% owner, Nerdy; 10% owner and Other, Super League Enterprise.
In numbers
- Trades disclosed
- 308
- Buys
- 18
- Sells
- 99
- Bought
- $385.7M
- Sold
- $7.2B
- Companies
- 50
- Companies where not an officer
- 49
- First trade
- 30 Sep 2005
- Last trade
- 5 Aug 2026
- Last filed
- 7 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Aug 2026filed 7 Aug 2026 | TPG Tpgoption or derivative · Capital Markets & Asset Management | SEC FORM 4 Code A | —3,577 at $0.00 | filing |
| 5 Aug 2026filed 7 Aug 2026 | TPG Tpgoption or derivative · Capital Markets & Asset Management | SEC FORM 4 Code A | —3,577 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | TPG TpgCapital Markets & Asset Management | SEC FORM 4 Code F | $1.8M40,950 at $43.15 | filing |
| 15 Jul 2026filed 17 Jul 2026 | TPG TpgCapital Markets & Asset Management | SEC FORM 4 Code F | $1.8M40,950 at $43.15 | filing |
| 26 Jun 2026filed 30 Jun 2026 | CBLL CeriBellMedical Devices | SEC FORM 4 Sold | $4.1M202,368 at $20.12 | filing |
| 11 May 2026filed 13 May 2026 | ODTX Odyssey Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code J | —423,111 | filing |
| 11 May 2026filed 13 May 2026 | ODTX Odyssey Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —18,272,789 | filing |
| 11 May 2026filed 13 May 2026 | ODTX Odyssey TherapeuticsBiotechnology | SEC FORM 4 Code J | —423,111 | filing |
| 11 May 2026filed 13 May 2026 | ODTX Odyssey TherapeuticsBiotechnology | SEC FORM 4 Code J | $42K2,351 at $18.00 | filing |
| 11 May 2026filed 13 May 2026 | ODTX Odyssey TherapeuticsBiotechnology | SEC FORM 4 Code C | —1,880,497 | filing |
| 11 May 2026filed 13 May 2026 | ODTX Odyssey TherapeuticsBiotechnology | SEC FORM 4 Bought | $25.0M1,388,889 at $18.00 | filing |
| 11 Feb 2026filed 13 Feb 2026 | TPG Tpgoption or derivative · Capital Markets & Asset Management | SEC FORM 4 Code A | —210,464 at $0.00 | filing |
| 11 Feb 2026filed 13 Feb 2026 | TPG Tpgoption or derivative · Capital Markets & Asset Management | SEC FORM 4 Code A | —210,464 at $0.00 | filing |
| 13 Jan 2026filed 15 Jan 2026 | TPG TpgCapital Markets & Asset Management | SEC FORM 4 Code F | $6.8M102,240 at $66.03 | filing |
| 13 Jan 2026filed 15 Jan 2026 | TPG TpgCapital Markets & Asset Management | SEC FORM 4 Code A | —151,503 | filing |
| 13 Jan 2026filed 15 Jan 2026 | TPG TpgCapital Markets & Asset Management | SEC FORM 4 Code F | $6.8M102,240 at $66.03 | filing |
| 13 Jan 2026filed 15 Jan 2026 | TPG TpgCapital Markets & Asset Management | SEC FORM 4 Code A | —151,503 | filing |
| 29 Dec 2025filed 30 Dec 2025 | TPG Twin Brook Capital Income Fund | SEC FORM 4 Bought | $100.0M3,976,000.86 at $25.15 | filing |
| 4 Nov 2025filed 6 Nov 2025 | TPG Tpgoption or derivative · Capital Markets & Asset Management | SEC FORM 4 Code A | —14,875 at $0.00 | filing |
| 19 Aug 2025filed 20 Aug 2025 | TPG Tpgoption or derivative · Capital Markets & Asset Management | SEC FORM 4 Code A | —482,083 at $0.00 | filing |
News
Odyssey Therapeutics Announces Encouraging Phase 2a Ulcerative Colitis ResultsODTX · rttnews.com · 20 Oct 2026Financial Comparison: CeriBell (NASDAQ:CBLL) and LogicMark (OTCMKTS:LGMKD)CBLL · dailypolitical.com · 20 Oct 2026
0 headlines in the last 90 days name James G. Coulter; 2 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.